Finn R - Search Results

1

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.

Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW. Lu DS, et al. Among authors: finn r. Hepatology. 2005 May;41(5):1130-7. doi: 10.1002/hep.20688. Hepatology. 2005. PMID: 15841454

2

Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model.

Finn RS, Bentley G, Britten CD, Amado R, Busuttil RW. Finn RS, et al. Liver Int. 2009 Feb;29(2):284-90. doi: 10.1111/j.1478-3231.2008.01762.x. Epub 2008 May 14. Liver Int. 2009. PMID: 18482274

3

A phase I/II trial of trastuzumab plus erlotinib in metastatic HER2-positive breast cancer: a dual ErbB targeted approach.

Britten CD, Finn RS, Bosserman LD, Wong SG, Press MF, Malik M, Lum BL, Slamon DJ. Britten CD, et al. Clin Breast Cancer. 2009 Feb;9(1):16-22. doi: 10.3816/CBC.2009.n.003. Clin Breast Cancer. 2009. PMID: 19299235 Free PMC article. Clinical Trial.

4

Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib.

Yeganeh M, Finn RS, Saab S. Yeganeh M, et al. Among authors: finn rs. Am J Transplant. 2009 Dec;9(12):2851-4. doi: 10.1111/j.1600-6143.2009.02860.x. Am J Transplant. 2009. PMID: 20021481 Free article.

5

Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?

Finn RS. Finn RS. Clin Cancer Res. 2010 Jan 15;16(2):390-7. doi: 10.1158/1078-0432.CCR-09-2084. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068087 Review.

6

Drug therapy: sorafenib.

Finn RS. Finn RS. Hepatology. 2010 May;51(5):1843-9. doi: 10.1002/hep.23676. Hepatology. 2010. PMID: 20432260 No abstract available.

7

Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.

Saab S, McTigue M, Finn RS, Busuttil RW. Saab S, et al. Exp Clin Transplant. 2010 Dec;8(4):307-13. Exp Clin Transplant. 2010. PMID: 21143097 Free article.

8

Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.

Sawey ET, Chanrion M, Cai C, Wu G, Zhang J, Zender L, Zhao A, Busuttil RW, Yee H, Stein L, French DM, Finn RS, Lowe SW, Powers S. Sawey ET, et al. Cancer Cell. 2011 Mar 8;19(3):347-58. doi: 10.1016/j.ccr.2011.01.040. Cancer Cell. 2011. PMID: 21397858 Free PMC article.

9

Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.

Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW. Hong JC, et al. Among authors: finn rs. J Am Coll Surg. 2011 Apr;212(4):514-20; discussion 520-1. doi: 10.1016/j.jamcollsurg.2010.12.005. J Am Coll Surg. 2011. PMID: 21463781

10

Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.

Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, Hiatt JR, Busuttil RW. Hong JC, et al. Among authors: finn r. Arch Surg. 2011 Jun;146(6):683-9. doi: 10.1001/archsurg.2011.116. Arch Surg. 2011. PMID: 21690444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

970 results

Search Page

Filters